DEIDRA BOBINCHECK: Open Payments
NPI 1770917346 · EUCLID, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,311 in 196 payments from 37 companies in 2025. Trend: 2023 $3,725 · 2024 $3,382 · 2025 $4,311
Food & beverage: $4,303Education: $8
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $480 |
| Corcept Therapeutics | 11 | $423 |
| Amgen Inc. | 13 | $274 |
| Otsuka America Pharmaceutical, Inc. | 11 | $260 |
| Lilly USA, LLC | 16 | $249 |
| ABBVIE INC. | 16 | $225 |
| AstraZeneca Pharmaceuticals LP | 9 | $205 |
| Phathom Pharmaceuticals, Inc. | 7 | $183 |
| Merck Sharp & Dohme LLC | 8 | $158 |
| PFIZER INC. | 13 | $143 |
Products named: Kerendia, Korlym, REXULTI, VOQUEZNA, MOUNJARO, VERQUVO, REPATHA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
